MAIA Biotechnology, Inc. Stock Issued During Period, Shares, New Issues
MAIA Biotechnology, Inc. (MAIA) reported Stock Issued During Period, Shares, New Issues of 11.11 thousand shares for the 1-month period ending 2022-05-31, per its 10-K filed 2023-03-24.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2023-03-24
- 2022-05-31: Stock Issued During Period, Shares, New Issues 1 month 11.11K shares.
- 2022-02-28: Stock Issued During Period, Shares, New Issues 2 month 263.73K shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month | Stock Issued During Period, Shares, New Issues 2 month |
|---|---|---|
| 2022-05-31 | 11.11K shares 10-K · filed 2023-03-24 | |
| 2022-02-28 | 263.73K shares 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |